Second, evidence that CD31-positive vascular structures in the proglumide-treated tumors were more linear and elongated than in untreated mice suggests a decrease in the abnormal vasculature that is characteristic of aggressive pancreatic carcinomas [35,39]. The gene discussed is PECAM1; the disease is exocrine pancreatic carcinoma.